Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leukemia

Showing results (1621-1630 of 9,628) with videos related to

Pageof 963
Sort By:
Leukemia|May 3, 2002
N-(4-hydroxyphenyl)retinamide increases ceramide and is cytotoxic to acute lymphoblastic leukemia cell lines, but not to non-malignant lymphocytesP H O'Donnell, W-X Guo, C P Reynolds, et al.
Leukemia|May 3, 2002
All-trans retinoic acid down-regulates prion protein expression independently of granulocyte maturationC Rybner, J Hillion, T Sahraoui, et al.
Leukemia|January 30, 2010
Development of resistance to dasatinib in Bcr/Abl-positive acute lymphoblastic leukemiaF Fei, S Stoddart, M Müschen, et al.
Leukemia|January 1, 1991
Molecular investigation of 19p13 in standard and variant translocations: the E12 probe recognizes the 19p13 breakpoint in cases with t(1;19) and acute leukemia other than pre-B immunophenotypeT Yamada, J M Craig, J M Hawkins, et al.
Leukemia|November 13, 2009
Mechanism of action of immunomodulatory drugs (IMiDS) in multiple myelomaH Quach, D Ritchie, A K Stewart, et al.
Leukemia|November 6, 2009
A comprehensive target selectivity survey of the BCR-ABL kinase inhibitor INNO-406 by kinase profiling and chemical proteomics in chronic myeloid leukemia cellsU Rix, L L Remsing Rix, A S Terker, et al.
Leukemia|September 27, 2018
Rational identification of a Cdc42 inhibitor presents a new regimen for long-term hematopoietic stem cell mobilizationWei Liu, Wei Du, Xun Shang, et al.
Leukemia|September 30, 2018
Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemiaDeepa Bhojwani, Richard Sposto, Nirali N Shah, et al.
Leukemia|October 17, 2018
Relapse after complete response in newly diagnosed multiple myeloma: implications of duration of response and patterns of relapseSurbhi Sidana, Nidhi Tandon, Angela Dispenzieri, et al.
Leukemia|April 10, 2019
Development and preclinical validation of a novel covalent ubiquitin receptor Rpn13 degrader in multiple myelomaYan Song, Paul M C Park, Lei Wu, et al.
Pageof 963

Showing results (1621-1630 of 9,628) with videos related to

Sort By:
Pageof 963
Leukemia|May 3, 2002
N-(4-hydroxyphenyl)retinamide increases ceramide and is cytotoxic to acute lymphoblastic leukemia cell lines, but not to non-malignant lymphocytesP H O'Donnell, W-X Guo, C P Reynolds, et al.
Leukemia|May 3, 2002
All-trans retinoic acid down-regulates prion protein expression independently of granulocyte maturationC Rybner, J Hillion, T Sahraoui, et al.
Leukemia|January 30, 2010
Development of resistance to dasatinib in Bcr/Abl-positive acute lymphoblastic leukemiaF Fei, S Stoddart, M Müschen, et al.
Leukemia|January 1, 1991
Molecular investigation of 19p13 in standard and variant translocations: the E12 probe recognizes the 19p13 breakpoint in cases with t(1;19) and acute leukemia other than pre-B immunophenotypeT Yamada, J M Craig, J M Hawkins, et al.
Leukemia|November 13, 2009
Mechanism of action of immunomodulatory drugs (IMiDS) in multiple myelomaH Quach, D Ritchie, A K Stewart, et al.
Leukemia|November 6, 2009
A comprehensive target selectivity survey of the BCR-ABL kinase inhibitor INNO-406 by kinase profiling and chemical proteomics in chronic myeloid leukemia cellsU Rix, L L Remsing Rix, A S Terker, et al.
Leukemia|September 27, 2018
Rational identification of a Cdc42 inhibitor presents a new regimen for long-term hematopoietic stem cell mobilizationWei Liu, Wei Du, Xun Shang, et al.
Leukemia|September 30, 2018
Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemiaDeepa Bhojwani, Richard Sposto, Nirali N Shah, et al.
Leukemia|October 17, 2018
Relapse after complete response in newly diagnosed multiple myeloma: implications of duration of response and patterns of relapseSurbhi Sidana, Nidhi Tandon, Angela Dispenzieri, et al.
Leukemia|April 10, 2019
Development and preclinical validation of a novel covalent ubiquitin receptor Rpn13 degrader in multiple myelomaYan Song, Paul M C Park, Lei Wu, et al.
Pageof 963